Skip to content

Comparing catheter-directed foam sclerotherapy to conventional open surgery for varicose vein

Catheter-directed Foam Sclerotherapy with High and Distal Ligation of Great Saphenous Vein versus High Ligation and Venous Stripping in Chronic Venous Insufficiency with Great Saphenous Vein Reflux: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220920002
Enrollment
146
Registered
2022-09-20
Start date
2023-01-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic venous insufficiency and great saphenous vein reflux varicose vein, venous insufficiency, sclerotherapy, stripping, surgery,

Interventions

The study intervention is catheter-directed foam sclerotherapy with high and distal ligation. First, high ligation of great saphenous vein is done using ultrasound-guided location as in controlled gro
Tessari&#039
s technique) is injected in to the catheter with continuous flushing of the vein via the introducer sheath. Complete filling of the vein with foam is confirmed before suturing close the incisions. Com
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
catheter-directed foam sclerotherapy with high and distal ligation,High ligation and venous stripping

Sponsors

Division of Vascular Surgery, Department of Surgery, Faculty of Medicine, Thammasat University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age between 18 - 80 years old, 2. Chronic insufficiency stage C2-6 with primary great saphenous vein reflux, 3.unilateral or bilateral great saphenous vein less than 10 mm, 4. patient who want to receive surgery.

Exclusion criteria

Exclusion criteria: 1. abnormal anatomy (duplicate saphenous vein), 2. other concomitant vein reflux, 3. history of deep vein thrombosis, 4. concomitant peripheral arterial occlusive (ankle brachial index < 0.9), 5. history of thrombophilia, 6. allergy to sclerotherapy, 7. history of superficial thrombophlebitis, 8. history of patent foramen ovale or cardiac murmur, 9. history of previous venous intervention, 10. end-stage renal disease, 11. history of migraine, 12. immobilization patients. 13. great saphenous vein with aneurysmal change, 14. cannot read and write or understand Thai language.

Design outcomes

Primary

MeasureTime frame
anatomical failure (great saphenous vein nonocclusion) at 1-2 weeks, 3 months, 6 months, and 1 year yes, partial occlusion without reflux, partial occlusion with reflux, no/ duplex scan

Secondary

MeasureTime frame
postoperative pain at 6 hour and 12 hour post-opearation Visual analog scale (0-10)/ interview,postoperative hematoma 1-2 weeks post-operation yes, no/ physical examination by attending physician,postoperative ecchymosis 1-2 weeks post-operation yes, no/ physical examination by attending physician,Postoperative wound infection 1-2 weeks post-operation yes, no/ physical examination by attending physician,Postoperative paresthesia 1-2 weeks post-operation yes, no/ physical examination by attending physician,Postoperative deep vein thrombosis 1-2 weeks post-operation yes, no/ duplex scan ,postoperative superficial thrombophlebitis 1-2 weeks post-operaion yes, no/ physical examination by attending physician,Postoperative venous matting 1-2 weeks post-operation yes, no/ physical examination by attending physician,postoperative transient blindness 1-2 weeks post-operation yes, no/ history taking by attending physician,time to return to normal activities at 1-2 weeks post-operation day/ interview by research team,time to return to work at 1-2 weeks post-operation day/ interview by research team,patient satisfaction at 1-2 weeks, 3 months, 6 months, and 1 year post-operation visual analog scores (1-10)/ interview by research team,clinical recurrence at 1-2 weeks, 3 months, 6 months, and 1 year post-operation yes, no/ physical examination by attending physician,Quality of life at 1-2 weeks, 3 months, 6 months, and 1 year post-operation EQ5D-5L and AVVQ/ patient report outcome measure recorded by research team ,venous severity scores at 1-2 weeks, 3 months, 6 months, and 1 year post-operation Venous clinical severity scores (VCSS)/interview and examination by attending physician,maximal pain score within 24 hours postoperatively Visual analog scale (0-10)/interview

Countries

Thailand

Contacts

Public ContactBoonying Siribumrungwong

Thammasat University Hospital

boonying22@gmail.com0899606259

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026